U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Famous Patents

Pong, the Atari creation that launched the computer game craze, came with these instructions: "Avoid missing ball for high score."

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 546/121 - Ring nitrogen is shared by the two cyclos


Subclass of Class 546 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the ring nitrogen is a member of both
No. of patents: 466
Last issue date: 05/22/2012


1                      
NumberTitleIssue Date
8183377Process for the preparation of imidazopyridines
A process for the preparation of imidazopyridines of formula (I), comprising reacting 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine with oxalyl chloride, followed by conversion of the chloride to oxoacetic acid, and further to compound of Formula (I).
05/22/2012
8163919Imidazopyridinyl benzamide mitotic kinesin inhibitors
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed. ...
04/24/2012
8063219Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
The invention concerns nitrogenated heterocyclic compounds, their preparation and use as antibacterial drugs, compounds of general formula (I) wherein R1 represents a (CH2)n-NHR2 or (CH...
11/22/2011
8063218Imidazopyridine inhibitors of IAP
The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I: wherein Q, X1, X2, Y, Z R1, R2, R3, R3′...
11/22/2011
8030492Compositions to effect neuronal growth
Compositions containing neurogenic agents for inhibition of neuron death and inducing proliferation of neural cells are disclosed. ...
10/04/2011
77007734-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors
In its many embodiments, the present invention provides a novel class of 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridine, pyrazolo[1,5-c]pyrimidine, and 2H-Indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1...
04/20/2010
7622584Imidazopyridine-based compound and organic light emitting diode including organic layer comprising the imidazopyridine-based compound
Imidazopyridine-based compounds and organic light emitting diodes (OLEDs) including organic layers including the imidazopyridine-based compounds are provided. The organic light emitting diodes including organic layers having the imidazopyridine-based compounds have ...
11/24/2009
7432278Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents
A method for treating a microbial infection, including an infection from a protozoan pathogen, such as Trypanosoma brucei rhodesiense and Plasmodium falciparum, in a subject in need thereof by administering to the subject an effective amount of a dicat...
10/07/2008
7417053Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
A pyrazolo[1,5-a]pyridine derivative represented by formula (I) and salt thereof exhibit excellent MAPKAP-K2 inhibitory activity. Accordingly, medicines comprising this compound as an active ingredient are expected to be valuable for treating or preventing diseases ...
08/26/2008
7417041Imidazopyrimidines as transforming growth factor (TGF) inhibitors
Novel fused heteroaromatic compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of tran...
08/26/2008
7399769Aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives
The present invention is concerned with aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives of formula wherein: R1, R2, and R3 are as defined herein and pharmaceutically acceptab...
07/15/2008
7385056Synthesis of heteroaryl acetamides
An improved process for the preparation of a heteroaryl acetamide from a heteroaryl α-hydroxyacetamide is provied. The process comprises directly hydrogenating the heteroaryl α-hydroxyacetamide in the presence of a strong acid, a halide and a catalyst. In one embo...
06/10/2008
7371871Inhibitors of glutaminyl cyclase
The present invention relates to compounds that act as inhibitors of QC including those represented by the general formulae 1 to 9: and combinations thereof for the treatment of neuronal disorders, especially Alzheimer's di...
05/13/2008
7365066Pyrazolopyridine derivatives as pharmaceutical agents
Novel pyrazolopyridine derivative compounds are disclosed and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors useful in the treatment of cancer and other disease states influenced by TGF beta. ...
04/29/2008
7358261Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alky...
04/15/2008
7348324Cyclic amine compounds as CCR5 antagonists
A compound of formula (I) (wherein R1 is a hydrogen atom, a hydrocarbon group which may be substituted, a non-aromatic heterocyclic group which may be substituted, R2 is a hydrocarbon group which may be substituted, a non-aromatic heterocyclic ...
03/25/2008
7348432Pyridine imidazoles and aza-indoles as progesterone receptor modulators
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the invention are useful in...
03/25/2008
7345050Pyrimidine compounds
The present invention relates to new compounds of the formula (I) a process for their preparation, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy, as well as intermediates used in the p...
03/18/2008
7345055Substituted C-imidazo [1,2-α] pyridin-3-yl-methylamines
Novel C-imidazo[1,2-α]pyridin-3-yl-methylamine compounds corresponding to formula I, wherein R1-R6 have the meanings provided in the description. Pharmaceutical compositions containing these compounds...
03/18/2008
7342025Substituted -imidazo[1,2-a]pyridin-3-yl-methylamines
Substituted C-imidazo [1,2-a]pyridine-3-yl methylamines and physiologically acceptable salts thereof, a method for the production thereof, pharmaceutical compositions containing these compounds, and pharmaceutical uses thereof, e.g., as NO synthase inhibitors. ...
03/11/2008
73267188-Substituted imidazopyridines
The present invention relates to 8-substituted imidazopyridines of a certain formula (1) in which the substitutents and symbols have the meanings indicated in the description. The compounds have gastric secretion...
02/05/2008
7326784Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
The invention relates to compounds of the formula 1, in which R1, R2, R3, Arom and PG have the meanings as indicated in the description. These compounds are valuable intermediates for the preparation of pharmaceu...
02/05/2008
73235697-phenylpyrazolopyridine compounds
A compound represented by the formula: [wherein R1 is methoxy, methylthio, ethyl, etc.; R5 and R6 are each independently cyclopropylmethyl, (4-tetrahydropyranyl)methyl, etc.; and ...
01/29/2008
7314940Jun kinase inhibitors
The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particula...
01/01/2008
7300470Dye composition comprising 2-chloro-6-methyl-3-aminophenol, at least two oxidation bases chosen from para-phenylenediamine derivatives and at least one associative thickening polymer
The present disclosure relates to a composition for oxidation dyeing keratin fibers, for instance, human keratin fibers such as the hair, comprising 2-chloro-6-methyl-3-aminophenol as a coupler, para-phenylenediamine or para-tolylenediamine as at least one first oxi...
11/27/2007
7285551Fused-ring compounds and use thereof as drugs
The present invention provides a fused ring compound of the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for he...
10/23/2007
7285666Pyrazolo[1,5-a] pyridines and medicines containing the same
Compounds represented by the general formula: [wherein R1 represents methoxy, ethyl, methylthio, etc., R2, R3 and R4 each represent hydrogen, a halogen, etc., R5
10/23/2007
7279580Imidazo-pyridine derivatives as ligands for GABA receptors
A class of 8-fluoro-3-phenylimidazo[1,2-α]pyridine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group, or by a pyrrolidinonyl group, which is directly attached or bridged by an oxygen atom or by a ...
10/09/2007
7276087Dye composition comprising 2-chloro-6-methyl-3-aminophenol as coupler, para-aminophenol and 3-methyl-4-aminophenol as oxidation bases and at least one associative thickening polymer
The present disclosure relates to a composition for oxidation dyeing keratin fibers, for instance human keratin fibers such as the hair, comprising 2-chloro-6-methyl-3-aminophenol as at least one coupler, para-aminophenol as at least one first oxidation base, 3-meth...
10/02/2007
7271178Heterocyclic inhibitors of MEK and methods of use thereof
Disclosed are compounds of the Formula V and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8, R9, R10, R11
09/18/2007
7265127βadrenergic agonists
The present invention relates to 2-imidazo[1,2-a]pyridine group containing β3 adrenergic receptor agonists or pharmaceutical salts thereof. ...
09/04/2007
7259263Method of synthesis of azole-containing amino acids
The invention relates to methods of synthesizing 2-substituted azole compunds of formula (I): The invention is also relates to compounds of formula (I) and to intermediate compounds in the synthesis method. ...
08/21/2007
7256293Imidazopyridine intermediates
The invention relates to compounds of the formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds are valuable intermediates for the preparation of pharmaceu...
08/14/2007
7241772βadrenergic agonists
The present invention relates to 2-imidazo[1,5-a]pyridine containing β3 adrenergic receptor agonists or pharmaceutical salts thereof. ...
07/10/2007
7238808Acetylenyl-pyrazolo-pyrimidine derivatives
The present invention relates to compounds of formula (I): wherein R1 to R3, A, M, L, E, G, and J are as defined in the description and claims. The invention also relates to a process for th...
07/03/2007
7230099Heterocyclic inhibitors of MEK and methods of use thereof
Disclosed are compounds of the Formula and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8, R9 and R10, W and Y are...
06/12/2007
72269268-fluoroimidazo 1,2-a pyridine derivatives as ligands for GABA receptors
A class of 8-fluoroimidazo[1,2-α]pyridine derivatives, substituted at the 3-position by an optionally substituted five-membered or six-membered heteroaromatic ring, being selective ligands for GABAA receptors, in particular having high affinity for the Î...
06/05/2007
7223866Imidazo[1,5-a]pyridine derivatives and methods for treating aldosterone mediated diseases
Compounds of the formula (I) provide pharmacological agents which are inhibitors of the P450 enzyme, aldosterone synthase, and thus may be employed for the treatment of aldosterone mediated conditions. Accordingl...
05/29/2007
7220756N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a CNS disorder relating to or affected by the 5-HT6 receptor ...
05/22/2007
7214677Benzamide, heteroarylamide and reverse amides
The present invention relates to novel to P2X7 inhibitors of formula I and to processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, an...
05/08/2007
1                      
 
Sign InRegister
Username  
Password   
forgot password?